A study of the suppressive effect of thioredoxin on airway inflammation using a mouse model of asthma showed that IL-13 and exotoxin production were significantly reduced in TRX-transgenic (TRX-Tg) mice, which reduced eosinophil recruitment and decreased mucus metaplasia. The gene discussed is IL13; the disease is asthma.